P. Schoenfeld Asset Management (PSAM)’s Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant PCPC.U Stock Holding History
Bought
Maintained
Sold
Other funds holding PCPC.U
MF
GCL
SRCM
KC
CL
MTCM
AA
P. Schoenfeld Asset Management (PSAM)'s PCPC.U Position: Q1 2021 in Review
P. Schoenfeld Asset Management (PSAM) sold out of Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant (PCPC.U) in Q1 2021, closing a stake of 250,000 shares — an estimated $6.53M sold.
P. Schoenfeld Asset Management (PSAM) first reported a position in PCPC.U in Q4 2020 and held it in 1 quarter. The position peaked at $6.53M in Q4 2020. 22 funds tracked by Wall St. Rank hold PCPC.U as of Q1 2021.
- P. Schoenfeld Asset Management (PSAM) reported no remaining Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position as of Q1 2021 after selling out during the quarter.
- P. Schoenfeld Asset Management (PSAM) sold 250,000 Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant shares in Q1 2021, an estimated $6.53M.
- P. Schoenfeld Asset Management (PSAM) first reported a position in Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant in Q4 2020 and held it in 1 quarter.
- P. Schoenfeld Asset Management (PSAM)'s Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant position peaked at $6.53M in Q4 2020.
- 22 funds tracked by Wall St. Rank held Periphas Capital Partnering Corporation CAPS, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant as of Q1 2021.
Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q1 2021, filed 14 May 2021.